| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SB 216763 | GDSC1000 | pan-cancer | AAC | -0.0019 | 1 |
| mRNA | MPS-1-IN-1 | GDSC1000 | pan-cancer | AAC | -0.0014 | 1 |
| mRNA | KIN001-260 | GDSC1000 | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | 0.0015 | 1 |
| mRNA | CAY10576 | CTRPv2 | pan-cancer | AAC | 0.0015 | 1 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | -0.0017 | 1 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | spautin-1 | CTRPv2 | pan-cancer | AAC | 0.0014 | 1 |
| mRNA | triptolide | CTRPv2 | pan-cancer | AAC | 0.0013 | 1 |
| mRNA | JQ-1:MK-0752 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0012 | 1 |